The Leadership Team at Nitrome Biosciences drives the strategic vision and direction of the company, focusing on the development of innovative drug therapies targeting newly identified enzymes associated with aging and neurodegenerative diseases. Comprising key executives in scientific research and drug discovery, the team oversees research initiatives, ensures alignment with clinical goals, and nurtures partnerships to accelerate the development of transformative treatments for conditions like Parkinson's disease and other age-related ailments.
View all